The Effect of Methods Used in Oral Antipyretic Administration on the Vital Findings of the Child With Fever

Pain Clinical Trial

Official title:

The Effect of Injector and Pacifier Used in Oral Antipyretic Administration on the Vital Findings of the Child With Fever

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05366049
• Other study ID #: E-59491012-604.01.02-2973
• Status: Completed
• Phase: N/A
• Start date: November 1, 2020
• Est. completion date: August 30, 2022

Study information

• Verified date: December 2022
• Source: Istanbul University - Cerrahpasa (IUC)
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Fever, one of the most common clinical journeys of childhood, makes up a fraction of emergency room admissions. About us-30. High fever, which is one of the first schools in infancy and childhood, can cause health problems such as not applying or starting the intervention. The most preferred method in the fire; antipyretic drug treatment in the hospital is routine . Antipyretics play a role in control plans and estimations of facts for cars of cars, the importance of word of mouth has some problems. In children, hospital, health care, injectors are grown from the breeder after completion, they can be created by red supplementation from the effects such as rearing without completion . resistance children; aspiration is risky, wrong dose is administered. It is stated in relation to teachers and verbal medicines for health. Hansen et al. Working with 61 babies aged 0-24 months, using a pacifier injector and a normal injector, children and temperature monitors. They are from the nipple injector used by mothers and women. There is a need for a new modification in the existing oral drug applications that will be able to support the adaptation and readiness of the child and to be able to effectively administer the drug. This work; Two different methods used to give antipyretic (medication pacifier and colored injector) were planned to be performed as pain, fever and purpose of life (respiratory rate, planning CTA) for the child.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: August 30, 2022
• Est. primary completion date: December 30, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A to 24 Months

Eligibility

Inclusion Criteria:

• Applying to the pediatric emergency department with a complaint of high fever (38ºC).
• Being prescribed an antipyretic (paracetamol) by a physician.
• Those whose parents are literate and agree to participate in the study.
• Patients with triage color classification Yellow and Green.
• Children between 0-24 months will be included in the study.

Exclusion Criteria:

• Having used antipyretics in the last 6 hours.
• Being prescribed an antipyretic other than paracetamol by the physician.
• Having trouble in sucking-swallowing coordination.
• Children with chronic disease and neuromotor developmental delay.

Related Conditions & MeSH terms

• Fever
• Heart Rate
• Pain
• Respiratory Rate

Intervention

Other:
• using a medicine pacifier to give acetaminophen
While giving acetaminophen, the effect on the amount of taking the drug, pain and vital parameters are observed by using the drug pacifier.

Locations

Country	Name	City	State
Turkey	Istanbul Unisversity- Cerrahpasa	Istanbul	Fatih

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul University - Cerrahpasa (IUC)

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	vital parameters	Respiratory rate/minute	before oral medications
Other	vital parameters	fever measurement (degrees centigrade)	before oral medications
Other	Vital parameters	Heart rate/minute	after medications 15 minute
Other	Vital parameters	Heart rate/minute	after medications 30 minute
Other	Vital parameters	Heart rate/minute	after medications 45 minute
Other	Vital parameters	Heart rate/minute	after medications 60 minute
Other	Pain score	Wong-baker pain scale. This scale is rated from 0 to 10. 0 is the pain of the pain, 10 is the pain to the beginning. shows. Pain by facial expression evaluation.	after medications 15 minute
Other	Pain score	Wong-baker pain scale. This scale is rated from 0 to 10. 0 is the pain of the pain, 10 is the pain to the beginning. shows. Pain by facial expression evaluation.	after medications 30 minute
Other	Pain score	Wong-baker pain scale. This scale is rated from 0 to 10. 0 is the pain of the pain, 10 is the pain to the beginning. shows. Pain by facial expression evaluation.	after medications 45 minute
Other	Pain score	Wong-baker pain scale. This scale is rated from 0 to 10. 0 is the pain of the pain, 10 is the pain to the beginning. shows. Pain by facial expression evaluation.	after medications 60 minute
Other	vital parameters	Respiratory rate/minute	after medications 15 minute
Other	vital parameters	Respiratory rate/minute	after medications 30 minute
Other	vital parameters	Respiratory rate/minute	after medications 45 minute
Other	vital parameters	Respiratory rate/minute	after medications 60 minute
Other	vital parameters	fever measurement (degrees centigrade)	after medications 15 minute
Other	vital parameters	fever measurement (degrees centigrade)	after medications 30 minute
Other	vital parameters	fever measurement (degrees centigrade)	after medications 45 minute
Other	vital parameters	fever measurement (degrees centigrade)	after medications 60 minute
Primary	Vital parameters	Heart rate/minute	before oral medications
Secondary	Pain score	Wong-baker pain scale. This scale is rated from 0 to 10. 0 is the pain of the pain, 10 is the pain to the beginning. shows. Pain by facial expression evaluation.	before oral medications